48 North Q1F2019 “In Pictures”

As “Gas in the Tank” picked up last Q…. it was going to be a hard trudge to repeat 4Q F2018 sales when they blew out a bunch of inventory to do it.  They entered Q1 F19 with under $1 million in inventory. The good news is they now have $2.4 million in inventory entering Q2 F19, which is a $1.1 million more than when they entered Q4 F2018.  Also, their biological assets have increased substantially and are also up $1 million over Q4F18 to $1.9 million. Take a look through the pics… if you have any Q’s… put them in The Dive Bar…

Continue Reading
Patent #7 Delivery of Cannabinoids for Non-Medicinal uses by Creso Pharma

This week we’re looking at a patent filed by an odd company. Creso Pharma is a cannabis company whose core operations are in Switzerland, Canada and Australia. They’re a publicly traded company listed on the Australian Securities Exchange. They own a cultivation facility in Nova Scotia, acquired through purchase of Mernova.  Creso has filed a patent through the Wold Intellectual Property Organization under WO2019030561A1 but have yet to go through the process of granting the patent in each country/region. The filed patent is titled “Composition containing cannabinoids with improved bioavailability”. Starting with the abstract:A food or nutritional or dietary composition or food or nutritional or dietary supplement…

Continue Reading
Tilray Q1 F2019 Rundown – March 31, 2019

Open up the fins and MDA and follow along During the Q Tilray closed on Manitoba Harvest +$400 million acquisition in Feb/19 which caused them to combine some inventory items, much to my chagrin. USD unless stated otherwise. Sales: Sales grew 48% QoQ largely on the back of the $6 million in revenue from Manitoba Harvest (MH).  Cannabis sales grew a total of $1.5 million or 9%, with flower showing a strong increase of 49% yet extracts dropping 24%. A 9% growth in cannabis in a market that Health Canada reports as declining is respectable. Adult use totaled $7.9 million while medical, including international,…

Continue Reading
Aurora Cannabis Q3 F2019 Rundown – March 31, 2019

First off… some very good disclosure in the MDA and the 1.5 hour conference call.  I think Cam said, “Aurora can have its cake and eat it too.” when commenting about having product to sell now and product to build out for Formats 2.0.  This is a very true statement. Three things to keep in mind for this Q on operations basis: Managed healthy increase in sales despite overall market being reportedly downWe are just seeing the leading edge of the Sky production capacity moving through the pipeline to sales. Next Q will be interesting for Gross Margin on this front.Someone is sitting on…

Continue Reading
Quick Seeds

I’ve been farting around with new genetics.  Not any from people I know in the Canadian industry, but from outside. ‘Quick seeds’. So, to orient: ‘ruderalis’ is a non-photoperiod dependent cultivar of cannabis.  For those who don’t grow, ‘cannabis’ is a flowering annual. Which means, the plant ‘vegetates’ (grows) until it flowers. The plant, when mature - usually 8-10 weeks from seed - is shortened from a 16/8 light cycle, to 12/12.  That means, instead of 16 hours of daylight & 8 hours darkness, we give the plant 12/12 hours of dark, and light. This induces flowering. The plant puts out colas, consumers are…

Continue Reading
Close Menu